Home › Epilepsy › Wisconsin
Epilepsy clinical trials in Wisconsin
3 studies for Epilepsy are looking for participants at sites in Wisconsin.
Cities in Wisconsin
AMT-260 Gene Therapy Study in Adults With Unilateral Refractory Mesial Temporal Lobe Epilepsy
- Medical College of Wisconsin, Milwaukee
RecruitingPhase 1/2
Ages 18 to 75 · All sexes · Updated Aug 24, 2026 · NCT06063850A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
- Advocate Aurora Research institute, St. Luke's Medical Center, Milwaukee
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Aug 10, 2026 · NCT05667142Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))
- Medical College of Wisconsin, Milwaukee
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Jun 9, 2026 · NCT05135091From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.